These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26949435)

  • 1. An overlap of Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Kataoka S; Serizawa N; Kitamura K; Suzuki A; Suzuki T; Shiga T; Shoda M; Hagiwara N
    J Arrhythm; 2016 Feb; 32(1):70-3. PubMed ID: 26949435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Differences in Japanese Patients Between Brugada Syndrome and Arrhythmogenic Right Ventricular Cardiomyopathy With Long-Term Follow-Up.
    Kataoka N; Nagase S; Kamakura T; Nakajima K; Wada M; Yamagata K; Ishibashi K; Inoue YY; Miyamoto K; Noda T; Aiba T; Izumi C; Noguchi T; Yasuda S; Kamakura S; Kusano K
    Am J Cardiol; 2019 Sep; 124(5):715-722. PubMed ID: 31284935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biventricular myocardial strain analysis using cardiac magnetic resonance feature tracking (CMR-FT) in patients with distinct types of right ventricular diseases comparing arrhythmogenic right ventricular cardiomyopathy (ARVC), right ventricular outflow-tract tachycardia (RVOT-VT), and Brugada syndrome (BrS).
    Heermann P; Fritsch H; Koopmann M; Sporns P; Paul M; Heindel W; Schulze-Bahr E; Schülke C
    Clin Res Cardiol; 2019 Oct; 108(10):1147-1162. PubMed ID: 30868222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic features of inherited diseases that predispose to the development of cardiac arrhythmias, long QT syndrome, arrhythmogenic right ventricular cardiomyopathy/dysplasia, and Brugada syndrome.
    Marcus FI
    J Electrocardiol; 2000; 33 Suppl():1-10. PubMed ID: 11265707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of desmoplakin mutation and delayed arrhythmogenic right ventricular cardiomyopathy/dysplasia after atrial septal defect closure.
    Yoshida A; Suzuki A; Kawada E; Tobita T; Serizawa N; Suzuki T; Arai K; Shiga T; Shoda M; Yosizawa S; Uto K; Masui K; Hagiwara N
    J Cardiol Cases; 2019 Apr; 19(4):111-114. PubMed ID: 30996754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characteristics of the Brugada electrocardiogram pattern in patients with arrhythmogenic right ventricular cardiomyopathy.
    Ueda N; Nagase S; Kataoka N; Nakajima K; Kamakura T; Wada M; Yamagata K; Ishibashi K; Inoue Y; Miyamoto K; Noda T; Aiba T; Izumi C; Noguchi T; Ohno S; Kusano K
    J Arrhythm; 2021 Oct; 37(5):1173-1183. PubMed ID: 34621416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic dilemmas: overlapping features of brugada syndrome and arrhythmogenic right ventricular cardiomyopathy.
    Hoogendijk MG
    Front Physiol; 2012; 3():144. PubMed ID: 22654761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brugada ECG pattern: a physiopathological prospective study based on clinical, electrophysiological, angiographic, and genetic findings.
    Duthoit G; Fressart V; Hidden-Lucet F; Simon F; Kattygnarath D; Charron P; Himbert C; Aouate P; Guicheney P; Lecarpentier Y; Frank R; Hébert JL
    Front Physiol; 2012; 3():474. PubMed ID: 23293604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worse Prognosis in Brugada Syndrome Patients With Arrhythmogenic Cardiomyopathy Features.
    Scheirlynck E; Chivulescu M; Lie ØH; Motoc A; Koulalis J; de Asmundis C; Sieira J; Chierchia GB; Brugada P; Cosyns B; Edvardsen T; Droogmans S; Haugaa KH
    JACC Clin Electrophysiol; 2020 Oct; 6(11):1353-1363. PubMed ID: 33121663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
    Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
    JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.
    Al-Ghamdi B; Shafquat A; Mallawi Y
    Ann Saudi Med; 2014; 34(5):415-26. PubMed ID: 25827699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges.
    Pinamonti B; Brun F; Mestroni L; Sinagra G
    World J Cardiol; 2014 Dec; 6(12):1234-44. PubMed ID: 25548613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice.
    Li KHC; Bazoukis G; Liu T; Li G; Wu WKK; Wong SH; Wong WT; Chan YS; Wong MCS; Wassilew K; Vassiliou VS; Tse G
    J Arrhythm; 2018 Feb; 34(1):11-22. PubMed ID: 29721109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The echocardiographic assessment of the right ventricle in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared with athletes and matched controls.
    Boczar KE; Alqarawi W; Green MS; Redpath C; Burwash IG; Dwivedi G
    Echocardiography; 2019 Apr; 36(4):666-670. PubMed ID: 30883925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D): Review of 16 Pediatric Cases and a Proposal of Modified Pediatric Criteria.
    Deshpande SR; Herman HK; Quigley PC; Shinnick JK; Cundiff CA; Caltharp S; Shehata BM
    Pediatr Cardiol; 2016 Apr; 37(4):646-55. PubMed ID: 26743400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria.
    Vermes E; Strohm O; Otmani A; Childs H; Duff H; Friedrich MG
    JACC Cardiovasc Imaging; 2011 Mar; 4(3):282-7. PubMed ID: 21414577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term CMR follow up of patients with right ventricular abnormality and clinically suspected arrhythmogenic right ventricular cardiomyopathy (ARVC).
    Femia G; Semsarian C; McGuire M; Sy RW; Puranik R
    J Cardiovasc Magn Reson; 2019 Dec; 21(1):76. PubMed ID: 31831077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic (ECG) clues to differentiate idiopathic right ventricular outflow tract tachycardia (RVOTT) from arrhythmogenic right ventricular cardiomyopathy (ARVC).
    Emkanjoo Z; Mollazdeh R; Alizadeh A; Kheirkhah J; Mohammadi Z; Khalili M; Azhari A; Shahrzad S
    Indian Heart J; 2014; 66(6):607-11. PubMed ID: 25634393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High interobserver variability in the assessment of epsilon waves: Implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Platonov PG; Calkins H; Hauer RN; Corrado D; Svendsen JH; Wichter T; Biernacka EK; Saguner AM; Te Riele AS; Zareba W
    Heart Rhythm; 2016 Jan; 13(1):208-16. PubMed ID: 26304715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.